Plain-English translation of NCT07244341 on ClinicalTrials.gov β Β· Source last updated Β· Translation generated Β· How we translate trials
Phase 1 β Testing in a small group (usually 20β80 people) to find a safe dose and watch for side effects.
This is an early-stage trial testing a new medication called paired with an existing prostate cancer drug called . Researchers want to find the right dose of the medication and learn whether this combination is safe and effective for men with advanced prostate cancer that no longer responds to standard hormone treatments.
Standard hormone therapies stop working for many men with advanced prostate cancer. This trial exists to explore whether adding this medication to an existing treatment might help patients whose cancer has become resistant to current options.
You likely qualify ifβ¦
You likely don't qualify ifβ¦
The trial has two parts. In the first part, researchers will gradually increase doses of the medication to find the safest level when combined with . In the second part, more participants will receive the medication at the doses that worked best. Throughout the trial, you will take both medications and have regular visits for blood tests, imaging scans, and check-ins to monitor how you're doing and watch for any side effects.
AI-generated summary from trial data Β· Jun 6, 2026 Β· Not medical advice
United States